Decred vs Enzyme — how do they compare? Decred trades at Rp214,206 (market cap Rp3,76T, Rp9,8M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Decred is far larger — about 28032.5× Enzyme's market cap, and Decred's supply is capped (17,6M / 21M DCR (84%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Decred for 12 Days and Enzyme for 29 Days on average.
| DCR | MLN | |
|---|---|---|
Market Cap | Rp3,76T | Rp134,13M |
Volume (24h) | Rp9,8M | Rp104,56M |
Circulating Supply | 17,6M / 21M DCR (84%) | 3,3M MLN |
Typical Hold Time | 12 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Decred (DCR) is currently trading at Rp215,504 with a market cap of Rp3.78 trillion, showing neutral technical signals overall. The asset is trading below key pivot points with bearish moving averages but neutral oscillators. With 84% of the maximum 21 million DCR supply in circulation and an average hold time of 12 days, the token shows moderate network participation. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with the price below resistance levels, though neutral RSI readings suggest potential consolidation. Key opportunities include potential bounce from support zones, while risks include bearish momentum and limited recent ecosystem activity. Investors should monitor for breaking above Rp229,365 resistance for bullish confirmation.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Decred, launched in 2016, is a cryptocurrency focused on security, user control, and adaptability. It uses a hybrid system combining Proof-of-Work (PoW) and Proof-of-Stake (PoS), allowing both miners and coin holders to participate in decision-making. This approach helps secure the network and ensures Decred can quickly adapt to changes.
Read more on DCR →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →